Know Cancer

or
forgot password

Randomized Multicenter Trial Assessing if Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Will Change Primary Treatment


Phase 4
18 Years
56 Years
Not Enrolling
Both
Breast Neoplasm

Thank you

Trial Information

Randomized Multicenter Trial Assessing if Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Will Change Primary Treatment


Completed: the study has concluded normally; participants are no longer being examined or
treated (i.e., last patient's last visit has occurred)


Inclusion Criteria:



- Women under 56 years of age

- Newly diagnosed breast cancer

- Swedish or English speaking

Exclusion Criteria:

- Claustrophobia

- Pregnancy

- Renal failure

- Metal items in patients

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Change of treatment plan

Outcome Description:

Did breast magnetic resonance imaging add information about the tumour that changed primary treatment plan

Outcome Time Frame:

14 days

Safety Issue:

No

Principal Investigator

Brita Arver, MD PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Karolinska University Hospital

Authority:

Sweden: Regional Ethical Review Board

Study ID:

POMB

NCT ID:

NCT01859936

Start Date:

February 2008

Completion Date:

April 2013

Related Keywords:

  • Breast Neoplasm
  • Breast Neoplasms
  • Neoplasms

Name

Location